Voya Financial (VOYA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Net income available to common shareholders rose to $201 million ($1.96 per diluted share) for Q2 2024, up from $154 million ($1.41 per diluted share) in Q2 2023, driven by investment gains and lower integration costs.
Adjusted operating EPS was $2.18, with strong fee-based revenue growth in Wealth and Investment Management offsetting higher loss ratios in Health Solutions.
On track to meet full-year 2024 EPS target of $8.25–$8.45, supported by revenue growth, spend control, and commercial momentum.
Increased quarterly dividend by 12.5% to $0.45 per share, reflecting robust capital generation and confidence in sustainable growth.
Wealth and Investment Management outpaced net revenue growth targets, while Health Solutions faced higher loss ratios but is taking repricing actions.
Financial highlights
Q2 2024 net income was $201 million, up from $154 million year-over-year, reflecting investment gains and lower integration costs.
Adjusted operating earnings were $223 million ($2.18 per share), down from $243 million ($2.21 per share) year-over-year, mainly due to lower Health Solutions underwriting gains.
Wealth Solutions adjusted operating earnings reached $214 million, up year-over-year due to strong fees and expense discipline.
Health Solutions adjusted operating earnings declined to $60 million, impacted by higher loss ratios despite 16% premium growth.
Investment Management adjusted operating earnings were $50 million, with net inflows of $4.8 billion and margin improvement.
Outlook and guidance
Full-year adjusted operating EPS guidance reaffirmed at $8.25–$8.45, assuming long-term alternative investment return of 9%.
On track to generate $0.8 billion of excess capital and achieve 2–4% net revenue growth, 30–33% adjusted operating margin, and 14–16% ROE for FY'24.
Health Solutions FY'24 aggregate loss ratio expected to be above the 69–72% range; repricing actions underway to improve 2025 results.
Investment Management targeting 2% organic net flow growth for FY'24, supported by strong net inflows and new fund launches.
Management expects continued growth in adjusted operating EPS through net revenue growth, margin expansion, and disciplined capital management.
Latest events from Voya Financial
- Record 2025 earnings, high ROE, and tech-driven efficiency support continued growth.VOYA
47th Annual Raymond James Institutional Investor Conference9 Mar 2026 - Record growth, disciplined M&A, and strong capital return set the stage for 2026 momentum.VOYA
UBS Financial Services Conference 20269 Feb 2026 - 2025 saw record earnings, $775M excess capital, and margin gains across all business lines.VOYA
Q4 20254 Feb 2026 - Wealth and investment gains offset Health margin pressure; OneAmerica deal to boost 2025.VOYA
Q3 202416 Jan 2026 - Wealth and investment growth offset Health headwinds; $800M returned, OneAmerica acquired.VOYA
Q4 202427 Dec 2025 - Stop-loss repricing, OneAmerica integration, and capital discipline drive 2025 growth outlook.VOYA
Bank of America Securities Financial Services Conference17 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor, all board-backed.VOYA
Proxy Filing1 Dec 2025 - Performance-driven growth, major acquisition, and strong governance define the year.VOYA
Proxy Filing1 Dec 2025 - Monthly distributions, higher yields, and strong global returns drive fund performance and appeal.VOYA
Status Update24 Nov 2025